Filter Results :

Your search for drugs returned 1035 reports

Sort by


Global Systemic Lupus Erythematosus (SLE) Drugs Market 2015-2019

22 Apr 2015  |  Published by:  Technavio
About SLE SLE is the most common form of lupus and is also called lupus. It is a chronic, autoimmune disease with signs and symptoms that can last for six months or for many years. It can affect any part of the body, such as the skin, joints, and organs (LFA, 2012). SLE occurs when the immune system...

$ 3,000.00

Read More

Global Gastrointestinal OTC Drugs Market 2015-2019

15 Apr 2015  |  Published by:  Technavio
About gastrointestinal OTC drugs OTC drugs are medications that do not require a prescription. In contrast, prescription drugs can be sold only to consumers having a legal prescription. OTC drugs are carefully chosen by regulatory agencies to ensure their safety and efficacy. Gastrointestinal OTC dr...

$ 3,000.00

Read More

United States Off-Label Drugs Market & Forecast

13 Apr 2015  |  Published by:  Renub Research
“United States Off–Label Drugs Market & Forecast” report provides a comprehensive analysis of the emerging Off–Label Drugs market. The report also entails commonly prescribed Off–Label Drugs, Perspective of Physicians, Patients, Pharmaceutical Companies and Regulatory Authorities, Off–labe...

$ 1,200.00

Read More

Respiratory Distress Syndrome-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

01 Apr 2015  |  Published by:  DelveInsight
SummaryDelveInsight’s, Respiratory Distress Syndrome-API Insights, 2015,report provides Respiratory Distress Syndrome drugs marketed details and API Manufacturers details across the globe along with the location. The report gives the clear idea on the United States Drug Master File (USDMF) and Europ...

$ 1,250.00

Read More

Recurrent Glioblastoma Multiforme (GBM)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

01 Apr 2015  |  Published by:  DelveInsight
SummaryDelveInsight’s, Recurrent Glioblastoma Multiforme (GBM)-API Insights, 2015,report provides Recurrent Glioblastoma Multiforme (GBM) drugs marketed details and API Manufacturers details across the globe along with the location. The report gives the clear idea on the United States Drug Master Fi...

$ 1,250.00

Read More

Respiratory Hypersensitivity-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

01 Apr 2015  |  Published by:  DelveInsight
SummaryDelveInsight’s, Respiratory Hypersensitivity-API Insights, 2015,report provides Respiratory Hypersensitivity drugs marketed details and API Manufacturers details across the globe along with the location. The report gives the clear idea on the United States Drug Master File (USDMF) and Europe ...

$ 1,250.00

Read More

Renal Anemia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

01 Apr 2015  |  Published by:  DelveInsight
SummaryDelveInsight’s, Renal Anemia-API Insights, 2015,report provides Renal Anemia drugs marketed details and API Manufacturers details across the globe along with the location. The report gives the clear idea on the United States Drug Master File (USDMF) and Europe DMF filed by worldwide countries...

$ 1,250.00

Read More

Relapsing Remitting Multiple Sclerosis (RRMS)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

01 Apr 2015  |  Published by:  DelveInsight
SummaryDelveInsight’s, Relapsing Remitting Multiple Sclerosis (RRMS)-API Insights, 2015,report provides Relapsing Remitting Multiple Sclerosis (RRMS) drugs marketed details and API Manufacturers details across the globe along with the location. The report gives the clear idea on the United States Dr...

$ 1,250.00

Read More

Relapsing Multiple Sclerosis (RMS)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

01 Apr 2015  |  Published by:  DelveInsight
SummaryDelveInsight’s, Relapsing Multiple Sclerosis (RMS)-API Insights, 2015,report provides Relapsing Multiple Sclerosis (RMS) drugs marketed details and API Manufacturers details across the globe along with the location. The report gives the clear idea on the United States Drug Master File (USDMF)...

$ 1,250.00

Read More

Relapsed Multiple Myeloma-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

01 Apr 2015  |  Published by:  DelveInsight
SummaryDelveInsight’s, Relapsed Multiple Myeloma-API Insights, 2015,report provides Relapsed Multiple Myeloma drugs marketed details and API Manufacturers details across the globe along with the location. The report gives the clear idea on the United States Drug Master File (USDMF) and Europe DMF fi...

$ 1,250.00

Read More

Retinitis Pigmentosa (Retinitis)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

01 Apr 2015  |  Published by:  DelveInsight
SummaryDelveInsight’s, Retinitis Pigmentosa (Retinitis)-API Insights, 2015,report provides Retinitis Pigmentosa (Retinitis) drugs marketed details and API Manufacturers details across the globe along with the location. The report gives the clear idea on the United States Drug Master File (USDMF) and...

$ 1,250.00

Read More

Refractory Multiple Myeloma-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

01 Apr 2015  |  Published by:  DelveInsight
SummaryDelveInsight’s, Refractory Multiple Myeloma-API Insights, 2015,report provides Refractory Multiple Myeloma drugs marketed details and API Manufacturers details across the globe along with the location. The report gives the clear idea on the United States Drug Master File (USDMF) and Europe DM...

$ 1,250.00

Read More

Restless Legs Syndrome-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

01 Apr 2015  |  Published by:  DelveInsight
SummaryDelveInsight’s, Restless Legs Syndrome-API Insights, 2015,report provides Restless Legs Syndrome drugs marketed details and API Manufacturers details across the globe along with the location. The report gives the clear idea on the United States Drug Master File (USDMF) and Europe DMF filed by...

$ 1,250.00

Read More

Refractory Anemia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

01 Apr 2015  |  Published by:  DelveInsight
SummaryDelveInsight’s, Refractory Anemia-API Insights, 2015,report provides Refractory Anemia drugs marketed details and API Manufacturers details across the globe along with the location. The report gives the clear idea on the United States Drug Master File (USDMF) and Europe DMF filed by worldwide...

$ 1,250.00

Read More

Respiratory Syncytial Virus (RSV) Infections-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

01 Apr 2015  |  Published by:  DelveInsight
SummaryDelveInsight’s, Respiratory Syncytial Virus (RSV) Infections-API Insights, 2015,report provides Respiratory Syncytial Virus (RSV) Infections drugs marketed details and API Manufacturers details across the globe along with the location. The report gives the clear idea on the United States Drug...

$ 1,250.00

Read More
Total 1035 records.